OÜ Genorama

Active Registry code 11538292 OÜ Tartu linn Registered 30 Sep 2008

OÜ Genorama is a OÜ based in Tartu linn, registry code 11538292, status: active. Main activity: Research and experimental development on social sciences and humanities. According to EMTA, turnover for Q3 2026 was €24 325 with 9 employees.

Turnover

24 325 €

↓ 13.5% vs Q2 2026

State taxes

10 753 €

↑ 60.6% vs Q2 2026

Labour taxes

12 008 €

↑ 61.4% vs Q2 2026

Employees

±0 vs Q2 2026

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

Turnover · Q3 2026 24 325 €

above 63% of companies

industry median 14 442 € · companies in the industry: 318
Labour taxes per employee 1 334 €

above 37% of companies

industry median 2 218 € · companies in the industry: 234
Revenue · 2025 124 696 €

above 91% of companies

industry median 0 € · companies in the industry: 1 073
Net profit margin · 2025 -1.7 %

above 27% of companies

industry median 13.5 % · companies in the industry: 597

Taxes and turnover

Q4 2023 – Q3 2026

Turnover, € Q3 2026: 24 325 € · −13.5% vs Q2 2026 · industry median 14 442 € · above 63% of the industry

Company
Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Labour taxes per employee, € Q3 2026: 1 334 € · +61.4% vs Q2 2026 · industry median 2 218 € · above 37% of the industry

Company
Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q3 2026: 9 · +0.0% vs Q2 2026

State taxes, € Q3 2026: 10 753 € · +60.6% vs Q2 2026

Figures by quarter
Quarter	Turnover, €	State taxes, €	Labour taxes, €	Employees
Q3 2026	24 325	10 753	12 008	9
Q2 2026	28 133	6 695	7 440	9
Q1 2026	44 128	13 446	9 523	8
Q4 2025	26 655	12 600	13 838	9
Q3 2025	29 886	12 602	13 841	11
Q2 2025	32 815	12 747	13 773	11
Q1 2025	32 111	11 101	11 996	11
Q4 2024	57 105	12 475	12 303	10
Q3 2024	50 318	12 276	12 515	10
Q2 2024	53 549	10 755	10 700	8
Q1 2024	40 941	9 227	8 850	9
Q4 2023	53 983	9 490	8 204	8
Q3 2023	56 133	9 268	8 448	8
Q2 2023	74 468	7 849	7 623	8
Q1 2023	85 811	10 765	7 841	8
Q4 2022	64 624	12 871	7 533	9
Q3 2022	61 387	8 230	7 494	9
Q2 2022	100 035	9 196	6 899	9
Q1 2022	43 678	7 575	6 112	9

Labour taxes per employee per month

445 €

Turnover per employee in the quarter

2 703 €

Q3 2026 · calculated from EMTA data

Financials by year

2016 – 2025

Revenue, € thousand 2025: 124 696 € · −38.7% vs 2024 · industry median 0 € · above 91% of the industry

Company
Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: -2 146 € · −104.2% vs 2024 · industry median 0 € · above 17% of the industry

Company
Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: -1.7 % · −26.8 pp vs the year before · industry median 13.5 % · above 27% of the industry

Company
Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 353 582 € · −1.5% vs 2024

Equity, € thousand 2025: 318 000 € · −0.7% vs 2024

Employees 2025: 3 · +0.0% vs 2024 · industry median 1 · above 65% of the industry

Company
Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year	Revenue, €	Net profit, €	Labour costs, €	Assets, €	Equity, €	Employees
2025	124 696	-2 146	113 733	353 582	318 000	3
2024	203 475	51 014	110 439	358 818	320 146	3
2023	250 074	25 048	77 808	290 926	269 132	3
2022	280 749	65 970	71 485	406 883	244 084	3
2021	209 986	34 753	63 368	375 660	178 114	2
2020	140 756	4 618	60 533	336 546	143 361	3
2019	121 831	1 532	59 136	310 416	138 743	2
2018	—	—	—	—	—	4
2017	—	—	—	—	—	4
2016	—	—	—	—	—	3
2015	—	—	—	—	—	3
2014	—	—	—	—	—	4
2013	—	—	—	—	—	5
2012	—	—	—	—	—	5
2011	—	—	—	—	—	6
2010	—	—	—	—	—	6
2009	—	—	—	—	—	0
2008	—	—	—	—	—	6

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin

-1.7 %

Net profit / revenue

Return on equity (ROE)

-0.7 %

Net profit / equity

Return on assets (ROA)

-0.6 %

Net profit / assets

Equity ratio

89.9 %

Equity / assets

Debt ratio

10.1 %

Liabilities / assets

Current ratio

2.77

Current assets / current liabilities

Revenue per employee

41 565 €

Revenue / average full-time employees

Labour cost per employee per month

3 159 €

Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister

Annual reports
Year	Period	Filed	Report	Documents
2025	1 Jan 2025 – 31 Dec 2025	30 Jun 2026	Company’s own	e-Äriregister
2024	1 Jan 2024 – 31 Dec 2024	30 Jun 2025	Company’s own	e-Äriregister
2023	1 Jan 2023 – 31 Dec 2023	27 Jun 2024	Company’s own	e-Äriregister
2022	1 Jan 2022 – 31 Dec 2022	26 Jun 2023	Company’s own	e-Äriregister
2021	1 Jan 2021 – 31 Dec 2021	30 Jun 2022	Company’s own	e-Äriregister
2020	1 Jan 2020 – 31 Dec 2020	28 Jun 2021	Company’s own	e-Äriregister
2019	1 Jan 2019 – 31 Dec 2019	3 Jul 2020	Company’s own	e-Äriregister

Board

Hardi Tamm
Board member · since 30 Jun 2023

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

OÜ Asper Biolab
Legal person · 11538286 · 2 556 €

100%

Beneficial owners

Katrin Tamm
Indirect ownership · since 7 Sep 2022
Hardi Tamm
Indirect ownership · since 27 Apr 2020

Founders and other persons

osaühing Asper Bio
Founder · 40 000 € · 29 Sep 2008

shared board members, owners or beneficial owners

Activities (EMTAK)

72201Research and experimental development on social sciences and humanities Main

Rulings 17

All rulings (PDF)

Rulings
Number, date	Title	Deadline	State	Document
Ä 20042280 / 14 19 Nov 2024	Amendment entry		In force 19 Nov 2024	PDF
Ä 20042280 / 13 2 Sep 2023	Amendment entry		In force 2 Sep 2023	PDF
Ä 20042280 / 12 30 Jun 2023	Amendment entry		In force 30 Jun 2023	PDF
Ä 20042280 / 11 12 May 2022	Amendment entry		In force 12 May 2022	PDF
Ä 20042280 / M3 10 May 2022	Ruling to eliminate deficiencies	13 May 2022	Deficiencies eliminated 12 May 2022	PDF
Ä 20042280 / 10 20 Feb 2020	Amendment entry		In force 20 Feb 2020	PDF
Ä 20042280 / M2 12 Feb 2020	Ruling to eliminate deficiencies	13 Mar 2020	Deficiencies eliminated 20 Feb 2020	PDF
Ä 20042280 / 9 30 Jun 2018	Amendment entry		In force 30 Jun 2018	PDF
Ä 20042280 / 8 17 Jan 2018	Amendment entry		In force 17 Jan 2018	PDF
Ä 20042280 / 7 22 Dec 2017	Amendment entry		In force 22 Dec 2017	PDF
Ä 20042280 / 6 4 Dec 2017	Amendment entry		In force 4 Dec 2017	PDF
Ä 20042280 / 5 6 Jul 2017	Amendment entry		In force 6 Jul 2017	PDF
Ä 20042280 / 4 10 Aug 2011	Amendment entry		In force 10 Aug 2011	PDF
Ä 20042280 / M1 8 Aug 2011	Ruling to eliminate deficiencies	8 Sep 2011	In force 8 Aug 2011	PDF
Ä 42280 / 3 5 Feb 2010	Amendment entry		In force 5 Feb 2010	PDF
Ä 42280 / 2 25 Feb 2009	Amendment entry		In force 25 Feb 2009	PDF
Ä 42280 30 Sep 2008	First entry		In force 30 Sep 2008	PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data

OÜ Genorama

Position in the industry Scientific research and development · EMTAK 72

Taxes and turnover

Financials by year

Financial ratios for 2025

Annual reports

Board

Right of representation

Owners

Beneficial owners

Founders and other persons

Related companies

Activities (EMTAK)

Rulings 17